Hyperemesis gravidarum affects 3% of pregnancies, causing severe vomiting and dehydration. Experts explain the causes, ...

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

We came across a bullish thesis on Fresenius Medical Care AG (NYSE:FMS) on ValueInvestorsClub by mimval. In this article, we ...

For patients who need to take oral medication twice daily, Professor Al-Shamsi recommended scheduling doses at Iftar and ...

Nutritionist Sarah Di Lorenzo takes a deep dive into the supplement that promises to stop ageing in its tracks.

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

A study reveals the impact of anaesthetic gases such as desflurane on healthcare emissions and how to reduce their carbon ...

Investigation launched into a case of ‘communication problems’ within healthcare team at Caritas Medical Centre in Sham Shui ...

The new formulation of Keytruda, currently under FDA review, is sparking conflict with Halozyme, which makes enzymes that ...

NAD IV drips may be the latest wellness trend capturing South Africa’s attention, promising energy boosts and anti-ageing ...

The FDA had approved Otulfi in September 2024 to treat Crohn’s disease, ulcerative colitis, psoriasis and active psoriatic arthritis. Information on pricing is not yet available.

The Supreme Court has dismissed a Fundamental Rights (FR) petition filed by Saman Ratnayake, a former Additional Secretary to ...